Luisa Riccardi Selected Research

Matrix Metalloproteinase 9 (Gelatinase B)

9/2008

Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luisa Riccardi Research Topics

Disease

4	Colitis 07/2009 - 11/2006
3	Body Weight (Weight, Body) 05/2012 - 03/2009
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2009 - 11/2006
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2005 - 11/2004
2	Edema (Dropsy) 07/2012 - 09/2011
2	Pancreatitis 07/2012 - 05/2012
2	Inflammation (Inflammations) 09/2011 - 03/2009
2	Neoplasms (Cancer) 04/2010 - 07/2008
1	Sarcoma (Soft Tissue Sarcoma) 04/2015
1	Hemorrhage 05/2012
1	Acute Necrotizing Pancreatitis 05/2012
1	Multiple Organ Failure (MODS) 09/2011
1	Carcinogenesis 04/2010
1	Prostatic Neoplasms (Prostate Cancer) 04/2010
1	Prostatic Intraepithelial Neoplasia 04/2010
1	Infections 07/2008

Drug/Important Bio-Agent (IBA)

4	2,4-dinitrofluorobenzene sulfonic acidIBA 07/2009 - 11/2006
4	DinitrobenzenesIBA 07/2009 - 11/2006
3	Sulfonic AcidsIBA 07/2009 - 11/2006
3	LigandsIBA 10/2005 - 11/2004
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2012 - 10/2005
2	Proteins (Proteins, Gene)FDA Link 07/2012 - 09/2011
2	CeruletideIBA 07/2012 - 05/2012
2	CytokinesIBA 07/2012 - 09/2011
2	GlucocorticoidsIBA 09/2011 - 03/2009
2	MelatoninIBA 09/2008 - 11/2006
2	Messenger RNA (mRNA)IBA 10/2005 - 11/2004
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2005 - 11/2004
2	Metalloproteases (Metalloproteinases)IBA 08/2005 - 11/2004
2	obeticholic acidIBA 08/2005 - 11/2004
1	Taurocholic Acid (Sodium Taurocholate)IBA 07/2012
1	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 07/2012
1	NF-kappa B (NF-kB)IBA 07/2012
1	EnzymesIBA 07/2012
1	Lipase (Acid Lipase)FDA Link 07/2012
1	Amylases FDA Link 07/2012
1	Protein CIBA 05/2012
1	drotrecogin alfa activated (Xigris)FDA Link 05/2012
1	Fc Receptors (Fc Receptor)IBA 09/2011
1	3-nitrotyrosineIBA 09/2011
1	ZymosanIBA 09/2011
1	TensinsIBA 04/2010
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2010
1	MicroRNAs (MicroRNA)IBA 04/2010
1	Ribonuclease III (RNase III)IBA 04/2010
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 04/2010
1	acteosideIBA 07/2009
1	thiobarbituric acidIBA 07/2009
1	Peroxidase (Myeloperoxidase)IBA 07/2009
1	Transcription Factors (Transcription Factor)IBA 03/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2009
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2009
1	teupoliosideIBA 03/2009
1	PPAR alphaIBA 03/2009
1	GlycosidesIBA 03/2009
1	AcidsIBA 09/2008
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2008
1	Matrix Metalloproteinases (MMPs)IBA 09/2008
1	3' Untranslated Regions (3' UTR)IBA 07/2008
1	Pharmaceutical PreparationsIBA 07/2008
1	PPAR gammaIBA 10/2005
1	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2005
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2004
1	CollagenIBA 11/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2004

Therapy/Procedure

1	Therapeutics 04/2015
1	Intraperitoneal Injections 07/2012
1	Ligation 10/2005